hta_admin | Health Technology Assessment Division

[Department Circular No. 2022- 0288] Nomination to the Health Technology Assessment Council (HTAC) Social Anthropologist Core Committee Member

Posted on June 10, 2022

[Department Circular No. 2022- 0291] Health Technology Assessment Council (HTAC) Recommendation to include Potassium Citrate 15 mEq Extended Release (ER) Tablet in the Philippine National Formulary

Posted on June 6, 2022

Link to the amended issuance

Tocilizumab for treatment of COVID-19

Posted on June 1, 2022

History

Lapatinib in the Treatment of HER2-Positive Breast Cancer Patients

Posted on May 31, 2022

Date of publication: May 31, 2021 Evidence Summary: https://drive.google.com/file/d/1VH5tkZyZr9sGWERXk8eXOyIQno456ixT/view Advisory on non-inclusion in PNF: https://drive.google.com/file/d/19PKRWWZ70bKUJBBuKyXnUjCtK01tzEgL/view (Proponents may submit appeals to hta@doh.gov.ph until 14 June 2021.) HTAC Recommendation Review:

[Department Circular No. 2022- 0257] Changes to the Topic Nomination and Appeals Processes of the Philippine HTA Process Guide

Posted on May 27, 2022